Bringing 4 complimentary events together in 2015, Cell Culture World Congress is the premier technical conference for Scientists, Principal Investigators, Managers and Engineers to gather to share ideas and debate strategies.
Upstream cell culture is the single, most critical process in developing safe and efficacious biologics and vaccines; the therapies of the future for unmet medical needs. Yet it is volatile as it is expensive since it depends on living material for cure. Stay ahead of your competition by streamlining and managing your cell culture processes using the novel and innovative strategies presented at this year's Cell Culture World Congress USA.
You can choose from the following conferences:
Contact us today to secure your position as a partner, sponsor or exhibitor at the show.
Why get involved?
Do you have an innovative product or service to help Scientists, Principal Investigators, Managers and Engineers stay one step ahead? Cell Culture World Congress is your best opportunity to profile your brand, develop key relationships, generate leads and make sales.
Make sure you’re there sponsoring or exhibiting to grab the attention of the prospects you need to meet.
Generate sales leads
Secure new partnerships
Meet one on one with your future clients
Showcase new services and products
Profile your brand
Develop key relationships
Educate the market about your offering
Forge strategic partnerships and initiate business relationships
Network with Scientists, Principal Investigators, Managers and Engineers
Your success at the show is dependent on the quality relationships you build. Take a look at the delegate list before the event, decide who you want to meet and we'll make it happen through our 1-2-1 Partnering service
10 organisations and individuals were recognised for their significant contributions on 24 March, at the 5th BioPharma Industry Awards Gala Dinner, held in conjunction with ...
The post Media Release : Winners of the 5th BioPharma Asia Industry Awards appeared first on Total Biopharma.
Regulatory bodies have increased the pressure on pharmaceutical companies to measure and monitor the risk of cognitive adverse events associated with investigational treatments. At the ...
The post Conducting a clinical safety review in drug development: the regulatory environment appeared first on Total Biopharma.
White paper provided by Sciformix. Click here for more information As the number of innovator pharmaceutical and generic manufacturer partnerships grow, the lines of responsibility for meeting pharmacovigilance ...
The post Whitepaper: A successful path to fulfilling pharmacovigilance obligations appeared first on Total Biopharma.
Innovation and strategy for pharmaceutical, biotech and R&D